Epilepsy in neurofibromatosis 1

Journal of Child Neurology

Volumn 18, Issue 5, 2003, Pages 338-342

  Vivarelli, Rossella ^a   Grosso, Salvatore ^a   Calabrese, Fulvia ^a   Farnetani, Maria Angela ^a   Di Bartolo, Rosanna ^a   Morgese, Guido ^a   Balestri, Paolo ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN INJURY; BRAIN MALFORMATION; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; FUNCTION TEST; GRAND MAL SEIZURE; HIGH RISK PATIENT; HUMAN; INFANT; MALE; MENTAL DEFICIENCY; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELIZAEUS MERZBACHER DISEASE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

EID: 0038758861     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180050501     Document Type: Article

References (22)

1. Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl J Med 1989;305:1617-1622.
2. Riccardi VM: Neurofibromatosis. Phenotype, Natural History, and Pathogenesis. Baltimore, Johns Hopkins University Press, 1992.
3. Friedman JM: Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999;89:1-6.
4. National Institutes of Health Consensus Development Conference: Neurofibromatosis. Conference statement. Arch Neurol 1988;45:575-578.
5. North KN: Neurofibromatosis 1 in children. Semin Pediatr Neurol 1998;5:231-242.
6. Cawthon RM, Weiss M, Xu G, et al: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193-201.
7. Gutmann DH, Wood DL, Collins FS: Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A 1991;88:9658-9662.
8. Carey JC, Viskochil DH: Neurofibromatosis type 1: A model condition for the study of the molecular basis of variable expressivity in human disorders. Am J Med Genet 1999;89:7-13.
9. Korf BR, Carranzana E, Holmes GL: Patterns of seizures observed in association with neurofibromatosis 1. Epilepsia 1993;34:616-620.
10. Kulkantrakorn K, Geller TJ: Seizures in neurofibromatosis 1. Pediatr Neurol 1998;19:347-350.
11. Kotagal P, Rothner D: Epilepsy in the setting of neurocutaneous syndromes. Epilepsia 1993;34:71-78.
12. Friedman JM, Birch PH: Type 1 neurofibromatosis: A descriptive analysis of the disorders in 1,728 patients. Am J Med Genet 1997;70:138-143.
13. Samuelsson B, Samuelsson S: Neurofibromatosis in Gothenburg, Sweden. Background, study design and epidemiology. Neurofibromatosis 1989;2:6-22.
14. Creange A, Zeller J, Rostaing-Rigattieri S, et al: Neurological complications of neurofibromatosis type 1 in adulthood. Brain 1999;122:473-481.
15. Hughes RAC: Neurological complications of neurofibromatosis 1, in Huson SM, Hughes RAC (eds): The Neurofibromatoses. A Pathogenetic and Clinical Overview. London, Chapman and Hall, 1994, 204-232.
16. Barkovich AJ: Pediatric Neuroimaging. Philadelphia, Lippincott, Wolliams&Wilkins, 2002.
17. Zhu Y, Romero MI, Ghosh P et al: Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 2001;15:859-876.
18. Li C, Cheng Y, Gutmann DA, et al: Differential localization of the neurofibromatosis 1 (NF1) gene product neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Dev Brain Res 2001;130:231-248.
19. Lakkis MM, Golden JA, O'Shea KS, et al: Neurofibromin deficiency in mice causes axencephaly is a modifier for splotch neural tube defects. Dev Biol 1999;212:80-92.
20. Rosman NP, Pearce J: The brain in multiple neurofibromatosis (von Recklinghausen's disease): A suggested neuropathological basis for the associated mental defect. Brain 1967;14:829-840.
21. Kato M, Takaschima S, Houdou S, et al: Cerebellar leptomeningeal heterotopia in neurofibromatosis type 1. Clin Neuropathol 1995;14:175-178.
22. Balestri P, Lucignani G, Fois A, et al: Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET. J Neurol Neurosurg Psychiatry 1994; 57:1479-1483.